Unique ID issued by UMIN | UMIN000030611 |
---|---|
Receipt number | R000034959 |
Scientific Title | Examination of influence on the skin prick test by intake of test food for persons with cedar pollen allergy |
Date of disclosure of the study information | 2018/01/03 |
Last modified on | 2018/03/14 13:12:49 |
Examination of influence on the skin prick test by intake of test food for persons with cedar pollen allergy
Examination of influence on the skin prick test by intake of test food for persons with cedar pollen allergy
Examination of influence on the skin prick test by intake of test food for persons with cedar pollen allergy
Examination of influence on the skin prick test by intake of test food for persons with cedar pollen allergy
Japan |
cedar pollen allergy
Clinical immunology | Adult |
Others
NO
To examination of influence on the skin prick test by intake of test food for persons with cedar pollen allergy.
Efficacy
Skin prick test (positive rate, rash diameter, redness diameter), questionnaire
Interventional
Single arm
Non-randomized
Open -no one is blinded
Self control
1
Prevention
Food |
Intake of test food for 4 weeks
20 | years-old | <= |
64 | years-old | >= |
Male and Female
(1) Males and females from 20 to 64 years of age
(2) Subjects who are aware of cedar pollen allergy
(3) Subjects with positive specific IgE test and skin prick test against cedar antibodies
(1) Subjects that regularly consume enhanced test food
(2) Subjects that regularly consume dietary supplements which may influence immune function
(3) Subjects with history of the allergic disease or anaphylactic shock (except for hay fever)
(4) Subjects undergoing medical treatment which may influence the outcome of the study
(5) Subjects with skin disease or a tattoo on the arm
(6) Night and day shift worker or manual laborer
(7) Subjects with intensive physical activity
(8) Subjects with poor adherence to the measurement procedures
(9) Subjects with severe diseases (e.g., diabetes, liver disease, kidney disease, or heart disease) and diseases that may affect the adrenal cortical hormone secretion
(10) Subjects potentially allergic to contents in test food
(11) Subjects who are judged inappropriate for the study according to the results of screening tests
(12) Subjects who intend to become pregnant during the study period or being pregnant or lactating
(13) Subjects who have participated in other clinical studies within one month from obtaining informed consent or intend to participate in other clinical studies after obtaining informed consent
(14) Subjects who are judged inappropriate for the study according to the results of lifestyle questionnaire
(15) Subjects who are judged inappropriate for the study by the physician
10
1st name | |
Middle name | |
Last name | Akihito Tomonaga |
Tana orthopedic surgery
Orthopedic surgery
15-7, Tana-cho, Aoba-ku, Yokohama-city, Kanagawa
045-989-2225
soyaku@kaiseikai-net.or.jp
1st name | |
Middle name | |
Last name | Takashi Nakagawa |
TTC Co., Ltd.
Clinical Research Planning Department
Seibu Shinkin Bank Ebisu Bldg., 1-20-2, Ebisunishi, Shibuya-ku, Tokyo
03-5459-5329
t.nakagawa@ttc-tokyo.co.jp
TTC Co., Ltd
KYOWA Co., Ltd.
Profit organization
NO
2018 | Year | 01 | Month | 03 | Day |
Unpublished
Completed
2017 | Year | 12 | Month | 19 | Day |
2018 | Year | 01 | Month | 04 | Day |
2017 | Year | 12 | Month | 28 | Day |
2018 | Year | 03 | Month | 14 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034959